FDA product code QGZ: Electrical Tumor Treatment Fields
QGZ is the FDA product code for electrical tumor treatment fields. It is a Class III device, reviewed by the Anesthesiology panel. Devices under QGZ reach the market by Unclassified; FDA lists no cleared 510(k)s for it.
Definition
The device is intended to treat patients with inoperable malignant pleural mesothelioma (MPM) concurrent to chemotherapy.
Classification
| Field | Value |
|---|---|
| Device name | Electrical Tumor Treatment Fields |
| Device class | Class III |
| Review panel | AN — Anesthesiology |
| Medical specialty | Unknown |
| Premarket route | Unclassified |
| Life-sustaining or supporting | Yes |
Recalls for QGZ devices
openFDA lists no recalls for product code QGZ.
Frequently asked questions
What is FDA product code QGZ?
QGZ is the FDA product code for electrical tumor treatment fields. It is a Class III device, reviewed by the Anesthesiology panel.
What device class is QGZ?
Class III. Typical premarket route: Unclassified.
Next steps
- Run an FDA pathway report with predicate devices for product code QGZ
- Run a recall and safety report across every QGZ manufacturer
- Watch product code QGZ for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Anesthesiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times